Zenocutuzumab

Zenocutuzumab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76948-1mg 1 mg - - -

7 - 10 business days*

374.00€
TGM-T76948-10mg 10 mg - - -

7 - 10 business days*

1,782.00€
TGM-T76948-25mg 25 mg - - -

7 - 10 business days*

2,684.00€
 
Description: Zenocutuzumab (MCLA-128) is a humanized antibody targeting the extracellular domains... more
Product information "Zenocutuzumab"
Description: Zenocutuzumab (MCLA-128) is a humanized antibody targeting the extracellular domains of HER2 and HER3. It can be used for research on tumors driven by NRG1 gene rearrangement. Target: HER, EGFR. References: Schram AM, et al. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements. Cancer Discov. 2022 May 2,12(5):1233-1247.
Keywords: R 040517 , MCLA128 , R040517 , PB 4188 , MCLA-128 , PB4188
Supplier: TargetMol
Supplier-Nr: T76948

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Zenocutuzumab"
Write a review
or to review a product.
Viewed